Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer

ACS Nano

Volumn 7, Issue 3, 2013, Pages 2078-2089

  Lee, Gee Young ^a   Qian, Wei Ping ^a   Wang, Liya ^a   Wang, Yongqiang Andrew ^b   Staley, Charles A ^a   Satpathy, Minati ^a   Nie, Shuming ^a   Mao, Hui ^a   Yang, Lily ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OCEAN NANOTECH LLC   (United States)

Author keywords

controlled drug release; drug delivery; gemcitabine; magnetic resonance imaging; pancreatic cancer; targeted cancer therapy; theranostic nanoparticle; uPAR

Indexed keywords

CONTROLLED DRUG RELEASE; GEMCITABINE; PANCREATIC CANCERS; TARGETED CANCER THERAPY; UPAR;

CHEMOTHERAPY; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; TUMORS;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; MAGNETITE NANOPARTICLE; NANOCAPSULE; UROKINASE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG SCREENING; FEMALE; HUMAN; METABOLISM; MOUSE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEOXYCYTIDINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICE, NUDE; NANOCAPSULES; NANOTECHNOLOGY; PANCREATIC NEOPLASMS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875682931     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn3043463     Document Type: Article

References (42)

1. Willett, C. G.; Czito, B. G.; Bendell, J. C.; Ryan, D. P. Locally Advanced Pancreatic Cancer J. Clin. Oncol. 2005, 23, 4538-4544
2. Warshaw, A. L.; Fernandez-del Castillo, C. Pancreatic Carcinoma N. Engl. J. Med. 1992, 326, 455-465
3. Hwang, R. F.; Moore, T.; Arumugam, T.; Ramachandran, V.; Amos, K. D.; Rivera, A.; Ji, B.; Evans, D. B.; Logsdon, C. D. Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression Cancer Res. 2008, 68, 918-926
4. Mahadevan, D.; Von Hoff, D. D. Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma Mol. Cancer Ther. 2007, 6, 1186-1197
5. Kalluri, R.; Zeisberg, M. Fibroblasts in Cancer Nat. Rev. Cancer 2006, 6, 392-401
6. Apte, M. V.; Park, S.; Phillips, P. A. Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells Pancreas 2004, 29, 179-187
7. Lopes, R. B.; Gangeswaran, R.; McNeish, I. A.; Wang, Y.; Lemoine, N. R. Expression of the IAP Protein Family Is Dysregulated in Pancreatic Cancer Cells and Is Important for Resistance to Chemotherapy Int. J. Cancer 2007, 120, 2344-2352
8. Miyamoto, H.; Murakami, T.; Tsuchida, K.; Sugino, H.; Miyake, H.; Tashiro, S. Tumor-Stroma Interaction of Human Pancreatic Cancer: Acquired Resistance to Anticancer Drugs and Proliferation Regulation Is Dependent on Extracellular Matrix Proteins Pancreas 2004, 28, 38-44
9. Yang, L.; Cao, Z.; Sajja, H. K.; Mao, H.; Wang, L.; Gene, H.; Xu, H.; Jiang, T.; Wood, W. C.; Nie, S. et al. Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging J. Biomed. Nanotechnol. 2008, 4, 1-11
10. Yang, L.; Mao, H.; Cao, Z.; Wang, Y. A.; Peng, X.; Wang, X.; Sajja, H. K.; Wang, L.; Duan, H.; Ni, C. et al. Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional Nanoparticles Gastroenterology 2009, 136, 1514-1525
11. Yang, L.; Peng, X. H.; Wang, Y. A.; Wang, X.; Cao, Z.; Ni, C.; Karna, P.; Zhang, X.; Wood, W. C.; Gao, X. et al. Receptor-Targeted Nanoparticles for in Vivo Imaging of Breast Cancer Clin. Cancer. Res. 2009, 15, 4722-4732
12. Blasi, F.; Carmeliet, P. uPAR: a Versatile Signalling Orchestrator Nat. Rev. Mol. Cell Biol. 2002, 3, 932-943
13. Tan, X.; Egami, H.; Nozawa, F.; Abe, M.; Baba, H. Analysis of the Invasion-Metastasis Mechanism in Pancreatic Cancer: Involvement of Plasmin(ogen) Cascade Proteins in the Invasion of Pancreatic Cancer Cells Int. J. Oncol. 2006, 28, 369-374
14. He, Y.; Liu, X. D.; Chen, Z. Y.; Zhu, J.; Xiong, Y.; Li, K.; Dong, J. H.; Li, X. Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis Clin. Cancer Res. 2007, 13, 3115-3124
15. Cantero, D.; Friess, H.; Deflorin, J.; Zimmermann, A.; Brundler, M. A.; Riesle, E.; Korc, M.; Buchler, M. W. Enhanced Expression of Urokinase Plasminogen Activator and its Receptor in Pancreatic Carcinoma Br. J. Cancer 1997, 75, 388-395
16. Chen, Y.; Zheng, B.; Robbins, D. H.; Lewin, D. N.; Mikhitarian, K.; Graham, A.; Rumpp, L.; Glenn, T.; Gillanders, W. E.; Cole, D. J. et al. Accurate Discrimination of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis Using Multimarker Expression Data and Samples Obtained by Minimally Invasive Fine Needle Aspiration Int. J. Cancer 2007, 120, 1511-1517
17. Hoyer-Hansen, G.; Ploug, M.; Behrendt, N.; Ronne, E.; Dano, K. Cell-Surface Acceleration of Urokinase-Catalyzed Receptor Cleavage Eur. J. Biochem. 1997, 243, 21-26
18. Rajagopal, V.; Kreitman, R. J. Recombinant Toxins That Bind to the Urokinase Receptor Are Cytotoxic without Requiring Binding to the Alpha(2)-Macroglobulin Receptor J. Biol. Chem. 2000, 275, 7566-7573
19. Stahl, A.; Mueller, B. M. The Urokinase-Type Plasminogen Activator Receptor, a GPI-Linked Protein, Is Localized in Caveolae J. Cell Biol. 1995, 129, 335-344
20. Nielsen, B. S.; Rank, F.; Illemann, M.; Lund, L. R.; Dano, K. Stromal Cells Associated with Early Invasive Foci in Human Mammary Ductal Carcinoma in Situ Coexpress Urokinase and Urokinase Receptor Int. J. Cancer 2007, 120, 2086-2095
21. Li, H.; Lu, H.; Griscelli, F.; Opolon, P.; Sun, L. Q.; Ragot, T.; Legrand, Y.; Belin, D.; Soria, J.; Soria, C. et al. Adenovirus-Mediated Delivery of a uPA/uPAR Antagonist Suppresses Angiogenesis-Dependent Tumor Growth and Dissemination in Mice Gene Ther. 1998, 5, 1105-1113
22. Pouliquen, D.; Le Jeune, J. J.; Perdrisot, R.; Ermias, A.; Jallet., P. Iron Oxide Nanoparticles for Use as an MRI Contrast Agent: Pharmacokinetics and Metabolism Magn. Reson. Imaging 1991, 9, 275-283
23. Lee, J. H.; Huh, Y. M.; Jun, Y. W.; Seo, J. W.; Jang, J. T.; Song, H. T.; Kim, S.; Cho, E. J.; Yoon, H. G.; Suh, J. S. et al. Artificially Engineered Magnetic Nanoparticles for Ultra-Sensitive Molecular Imaging Nat. Med. 2007, 13, 95-99
24. Moore, A.; Medarova, Z.; Potthast, A.; Dai, G. In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe Cancer Res. 2004, 64, 1821-1827
25. Nasongkla, N.; Bey, E. J.; Ren, H.; Ai, Khemtong, C.; Guthi, J. S.; Chin, S. F.; Sherry, A. D.; Boothman, D. A.; Gao, J. Multifunctional Polymeric Micelles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems Nano Lett. 2006, 6, 2427-2430
26. Lu, Z. R.; Kopecková, P.; Kopecek, J. Polymerizable Fab′ Antibody Fragments for Targeting of Anticancer Drugs Nat. Biotechnol. 1999, 17, 1101-1104
27. Naqvi, S. A.; Matzow, T.; Finucane, C.; Nagra, S. A.; Ishfaq, M. M.; Mather, S. J.; Sosabowski, J. Insertion of a Lysosomal Enzyme Cleavage Site into the Sequence of a Radiolabeled Neuropeptide Influences Cell Trafficking in Vitro and in Vivo Cancer Biother. Radiopharm. 2010, 25, 89-95
28. Lammers, T.; Subr, V.; Ulbrich, K.; Peschke, P.; Huber, P. E.; Hennink, W. E.; Storm, G. Simultaneous Delivery of Doxorubicin and Gemcitabine to Tumors in Vivo Using Prototypic Polymeric Drug Carriers Biomaterials 2009, 30, 3466-3475
29. Niedergethmann, M.; Wostbrock, B.; Sturm, J. W.; Willeke, F.; Post, S.; Hildenbrand, R. Prognostic Impact of Cysteine Proteases Cathepsin B and Cathepsin L in Pancreatic Adenocarcinoma Pancreas 2004, 29, 204-211
30. von Burstin, J.; Eser, S.; Seidler, B.; Meining, A.; Bajbouj, M.; Mages, J.; Lang, R.; Kind, A. J.; Schnieke, A. E.; Schmid, R. M. et al. Highly Sensitive Detection of Early-Stage Pancreatic Cancer by Multimodal Near-Infrared Molecular Imaging in Living Mice Int. J. Cancer 2008, 123, 2138-2147
31. Esera, S.; Messera, M.; Eserb, P.; von Werdera, A.; Seidlera, B.; Bajbouja, M.; Vogelmanna, R.; Meininga, A.; von Burstina, J.; Algüla, H. et al. In Vivo Diagnosis of Murine Pancreatic Intraepithelial Neoplasia and Early-Stage Pancreatic Cancer by Molecular Imaging Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 9945-9950
32. Yu, W. W.; Falkner, J. C.; Yavuz, C. T.; Colvin, V. L. Synthesis of Monodisperse Iron Oxide Nanocrystals by Thermal Decomposition of Iron Carboxylate Salts Chem. Commun. (Cambridge, U.K.) 2004, 20, 2306-2307
33. Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. Nanoparticles for Drug Delivery: The Need for Precision in Reporting Particle Size Parameters Eur. J. Pharm. Biopharm. 2008, 69, 1-9
34. Merriman, R. L; Hertel, L. W.; Schultz, R. M.; Houghton, P. J.; Houghton, J. A.; Rutherford, R. G.; Tanzer, L. R.; Boder, G. B.; Grindey, G. B. Comparison of the Antitumor Activity of Gemcitabine and Ara-C in a Panel of Human Breast, Colon, Lung and Pancreatic Xenograft Models Invest. New Drugs 1996, 14, 243-247
35. Hermann, P. C.; Huber, S. L.; Herrler, T.; Aicher, A.; Ellwart, J. W.; Guba, M.; Bruns, C. J.; Heeschen, C. Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer Cell Stem Cell 2007, 1, 313-323
36. Hilbig, A.; Oettle, H. G. Gemcitabine in the Treatment of Metastatic Pancreatic Cancer Expert Rev. Anticancer Ther. 2008, 8, 511-523
37. Welch, B. L. The Generalization of "Student's" Problem When Several Different Population Variances Are Involved Biometrika 1947, 34, 28-35
38. 2 J. Mod. Appl. Stat. Methods 2002, 1, 461-472
39. 1-Weighted Ultrashort Echo Time Method for Positive Contrast Imaging of Magnetic Nanoparticles and Cancer Cells Bound with the Targeted Nanoparticles J. Magn. Reson. Imaging 2011, 33, 194-202
40. Tomchick, R.; Saslaw, L. D.; Waravdekar, V. S. Mouse Kidney Cytidine Deaminase. Purification and Properties J. Biol. Chem. 1968, 243, 2534-2537
41. Harisinghani, M. G.; Barentsz, J.; Hahn, P. F.; Deserno, W. M.; Tabatabaei, S.; van de Kaa, C. H.; de la Rosette, J.; Weissleder, R. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer N. Engl. J. Med. 2003, 348, 2491-2499
42. Schultz, J. F.; Bell, J. D.; Goldstein, R. M.; Kuhn, J. A.; McCarty, T. M. Hepatic Tumor Imaging Using Iron Oxide MRI: Comparison with Computed Tomography, Clinical Impact, and Cost Analysis Ann. Surg. Oncol. 1999, 6, 691-698